Deferasirox versus deferoxamine.
Publication
, Journal Article
Martin, MG; Arcasoy, MO
Published in: Blood
July 15, 2006
Duke Scholars
Published In
Blood
DOI
ISSN
0006-4971
Publication Date
July 15, 2006
Volume
108
Issue
2
Start / End Page
774 / 775
Location
United States
Related Subject Headings
- Triazoles
- Randomized Controlled Trials as Topic
- Patient Compliance
- Immunology
- Humans
- Deferoxamine
- Deferasirox
- Data Interpretation, Statistical
- Benzoates
- 3213 Paediatrics
Citation
APA
Chicago
ICMJE
MLA
NLM
Martin, M. G., & Arcasoy, M. O. (2006). Deferasirox versus deferoxamine. Blood, 108(2), 774–775. https://doi.org/10.1182/blood-2006-02-002436
Martin, Mike G., and Murat O. Arcasoy. “Deferasirox versus deferoxamine.” Blood 108, no. 2 (July 15, 2006): 774–75. https://doi.org/10.1182/blood-2006-02-002436.
Martin MG, Arcasoy MO. Deferasirox versus deferoxamine. Blood. 2006 Jul 15;108(2):774–5.
Martin, Mike G., and Murat O. Arcasoy. “Deferasirox versus deferoxamine.” Blood, vol. 108, no. 2, July 2006, pp. 774–75. Pubmed, doi:10.1182/blood-2006-02-002436.
Martin MG, Arcasoy MO. Deferasirox versus deferoxamine. Blood. 2006 Jul 15;108(2):774–775.
Published In
Blood
DOI
ISSN
0006-4971
Publication Date
July 15, 2006
Volume
108
Issue
2
Start / End Page
774 / 775
Location
United States
Related Subject Headings
- Triazoles
- Randomized Controlled Trials as Topic
- Patient Compliance
- Immunology
- Humans
- Deferoxamine
- Deferasirox
- Data Interpretation, Statistical
- Benzoates
- 3213 Paediatrics